Navigation Links
Sun-induced skin cancer: new discovery permits doctors to assess genetic risk
Date:6/2/2010

As people head to the beach this summer, very few if any, really know how likely they are to develop skin cancer from their outdoor fun. That's about to change, thanks to a new discovery by an international team of scientists that makes it possible for doctors to access people's personal risk for skin cancer.

In a new research report appearing online in The FASEB Journal (http://www.fasebj.org), these researchers describe for the first time the chain of molecular events that increase one's risk of skin cancer. This discovery may lead to new tests that access personal skin cancer risk as well as a new generation of sunscreens that increase the skin's ability to protect itself from the sun's damaging rays.

"Our study heralds the onset of personalized medicine for individuals who carry a change in the MC1R gene," said Zalfa A. Abdel-Malek, Ph.D., a researcher involved in the work from the Department of Dermatology at the University of Cincinnati. "The data we have obtained allows us to better predict which individuals will be at risk for skin cancer, as well as potentially why and to what degree. In the future, genetic testing for MC1R gene changes may be clinically available so that individuals can be made aware of the molecular basis of their risk prior to development of cancer."

Abdel-Malek and colleagues found that when a pigmentation gene called the "melanocortin 1 receptor" or MC1R does not function properly, skin cells do not respond to a hormone, called α-MSH, which causes cells to produce dark pigmentation to protect themselves from ultraviolet rays. To make this discovery, the researchers studied 21 human skin cell cultures that express the MC1R gene in different ways. Each culture was studied for expression of genetic changes of MC1R, pigment levels and the ability to respond to α-MSH. The researchers also exposed the cell cultures to ultraviolet rays and measured the a
'/>"/>

Contact: Cody Mooneyhan
cmooneyhan@faseb.org
301-634-7104
Federation of American Societies for Experimental Biology
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pancreatic cancer: Minimally invasive treatments and possible links to GI diseases
2. Prostate cancer: Risk increases with the number of affected family members
3. Brain cancer: Study focuses on forgotten cells
4. Castrate-Metastatic Prostate Cancer: Therapeutic Considerations for Advanced Disease
5. Scanning for skin cancer: Infrared system looks for deadly melanoma
6. Personalizing cancer: Creating biomarkers from tumor DNA
7. Lung Cancer: Large Impact, Little Funding
8. Exposing the Double Standard of the Forgotten Cancer: Biggest Cancer Killer for Women and Men, Lung Cancer, Receives Least Research Funds
9. U of A discovery offers promising research for spinal-cord injury treatments
10. Discovery of Stem Cell Illuminates Human Brain Evolution, Points To Therapies
11. Gene discovery potential key to cost-competitive cellulosic ethanol
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... of a rat and a robot could revolutionise advances ... robotics researcher. , Dr Michael Milford from QUT,s ... new computer algorithms to enable robots to navigate intelligently, ... a very Frankenstein type of project," Dr Milford said. ... because we,re taking the eyes of a human and ...
(Date:10/1/2014)... Familylifeinsurancequotes.org has released a new ... senior citizens. , Senior citizens can qualify for ... coverage to seniors who are over 50 years old. ... taking a medical examination. , Term life insurance with ... clients can qualify. Having life insurance during retirement is ...
(Date:10/1/2014)... (PRWEB) October 01, 2014 First Warning ... abnormal circadian cellular changes throughout the body, announced the ... to better address the company’s breadth of upcoming product ... breast cancer screening technology. , “Our initial focus will ... system which detects abnormal circadian cellular changes over time,” ...
(Date:10/1/2014)... N.C. A new genetic finding from Duke Medicine ... anxiety and depression might also be hard-wired to gain ... and heart disease. , An estimated 13 percent of ... genetic susceptibility, and knowing this could help them reduce ... diet, exercise and stress management. , "Genetic susceptibility, psychosocial ...
(Date:10/1/2014)... 01, 2014 NoteSwift Inc., announced today ... 10.0, 12.1 and 13.0. NoteSwift is the bridge between ... to navigate and document clinical information at the point ... creating a patient note by more than half – ... major pain points providers state impedes EHR use according ...
Breaking Medicine News(10 mins):Health News:Robot researcher combines nature to nurture 'superhuman' navigation 2Health News:Affordable Term Life Insurance - Senior Citizens Can Qualify for Coverage! 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 2Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 3Health News:First Warning Systems Changes Name to Cyrcadia Health to Better Reflect Core Competency and Goals of Company 4Health News:Gene interacts with stress and leads to heart disease in some people 2Health News:NoteSwift Joins Allscripts Developer Program 2Health News:NoteSwift Joins Allscripts Developer Program 3
... California, San Francisco has discovered a new way to predict ... relative levels of three types of immune cells within a ... treatment. Moreover, the UCSF team showed that they could ... these drugs to mice, in combination with chemotherapy, significantly slowed ...
... Using new genetic information, scientists have linked a commonly ... reduced risk of bladder cancer, according to findings presented ... 2-6, and simultaneously published in Cancer Prevention Research, a ... Jian Gu, Ph.D., assistant professor of epidemiology at ...
... FRIDAY, April 1 (HealthDay News) -- At-home pregnancy tests can ... the way and if it is time to call your ... tantalizing clues about future health risks -- are still in ... may puzzle or even panic consumers who don,t seek professional ...
... News) -- Reducing cancer patients, stress may benefit their ... chronic stress associated with cancer diagnosis accelerated shortening of ... the chromosome from deteriorating, breaking apart or joining with ... investigators also wanted to see if counseling sessions designed ...
... HealthDay Reporter , FRIDAY, April 1 (HealthDay News) ... wrinkles by freezing the nerves shows promise in early ... approved by the U.S. Food and Drug Administration, could ... injectable forms of Botulinum toxin type A, a neurotoxin ...
... new data presented today at the International Liver CongressTM ... (HCV) patients suppressed the emergence of resistant variants and ... - undetectable HCV RNA - 12 weeks after treatment ... were given four drugs in combination; pegylated Interferon-alpha (PegIFN-alpha); ...
Cached Medicine News:Health News:UCSF team discovers new way to predict breast cancer survival and enhance effectiveness of treatment 2Health News:UCSF team discovers new way to predict breast cancer survival and enhance effectiveness of treatment 3Health News:Genetic variation linked to longer telomeres and lower risk of bladder cancer 2Health News:Do At-Home Genetic Tests Tell Too Much and Explain Too Little? 2Health News:Do At-Home Genetic Tests Tell Too Much and Explain Too Little? 3Health News:Does Stress Reduction Benefit Cancer Patients' Health? 2Health News:Freezing Wrinkles a Possible Alternative to Botox 2Health News:Freezing Wrinkles a Possible Alternative to Botox 3Health News:Quadruple therapy shows 100 percent SVR for HCV patients previously unresponsive to treatment 2
(Date:9/30/2014)... Group finds that the Asia Pacific dental ... , India , Japan ... implant procedure volumes will grow as physicians are increasingly trained on ... findings from Decision Resources Group,s coverage of the Asia ... implant penetration: Penetration of dental implants among the Asia ...
(Date:9/30/2014)... 30, 2014 According ... Market by Product [Enzymes (Glycosyltransferase, Neuraminidase, Glycosidase), ... Reagents], Application (Immunology, Oncology) & by End ... by MarketsandMarkets, provides a detailed overview of ... market trends, and strategies impacting the global ...
(Date:9/30/2014)... ANGELES , Sept. 30, 2014   Easy ... shopping destination , today announced that it now offers ... . AirSense CPAPs are the first sleep apnea therapy ... it simple and easy to track and share real-time ... overall effectiveness of their CPAP therapy.  In addition, the ...
Breaking Medicine Technology:Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 2Asia Pacific Dental Implant Market Will Grow at a Strong Rate Through 2023 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 2Glycobiology / Glycomics Market Worth $928.11 Million by 2019 3Glycobiology / Glycomics Market Worth $928.11 Million by 2019 4Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 2Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 3Easy Breathe Now Offers World's First "Smart" CPAP Device to Treat Sleep Apnea 4
... HIGHLIGHTS:2011 Results (all percentages are to comparable periods ... increased 11% to $626 million. Q3 sales grew organically by ... organically by 4% and 2%, respectively.  Recently completed acquisitions contributed ... contributed an additional 5% to reported sales growth in Q3. ...
... Oct. 25, 2011 Abbott (NYSE: ABT ... – one undergraduate and one graduate – living with ... Undergraduate Student Scholarship, and Emily Kramer-Golinkoff, winner of the ... with CF who were eligible to receive the two ...
Cached Medicine Technology:Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 2Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 3Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 4Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 5Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 6Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 7Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 8Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 9Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 10Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 11Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 12Sigma-Aldrich (NASDAQ:SIAL) Reports 25% Increase in Q3 Diluted EPS. Q3 Sales Increase 11%. Full Year 2011 Diluted EPS Raised to $3.73 to $3.81. 13Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees 2Abbott Awards CFCareForward Scholarships to Two Students Living With Cystic Fibrosis Pursuing Undergraduate and Graduate Degrees 3
Jewelers bipolar forceps, 10 cm....
European bipolar foot activated forceps....
Straight, blunt and pointed tips....
Cushing bayonet....
Medicine Products: